Breaking News Instant updates and real-time market news.

AAXN

Axon

$60.89 /

+0.77 (+1.28%)

, ABB

ABB

$19.51 /

+0.07 (+0.36%)

04:55
04/12/19
04/12
04:55
04/12/19
04:55

Security Industry Association to hold an expo

ISC West 2019 will be held in Las Vegas on April 8-12.

AAXN

Axon

$60.89 /

+0.77 (+1.28%)

ABB

ABB

$19.51 /

+0.07 (+0.36%)

ABM

ABM

$37.00 /

-0.01 (-0.03%)

AES

AES Corp.

$18.07 /

+0.02 (+0.11%)

AXE

Anixter

$59.99 /

-0.37 (-0.61%)

BCO

Brink's

$79.76 /

+0.92 (+1.17%)

COF

Capital One

$86.27 /

+0.67 (+0.78%)

DELL

Dell Technologies

$63.84 /

+0.57 (+0.90%)

DMRC

Digimarc

$31.19 /

+0.61 (+1.99%)

FLIR

Flir Systems

$49.32 /

+0.53 (+1.09%)

INVE

Identiv

$4.68 /

-0.06 (-1.27%)

NICE

Nice

$125.50 /

+0.66 (+0.53%)

REZI

Resideo

$19.96 /

+0.07 (+0.35%)

SSTI

ShotSpotter

$45.84 /

-0.47 (-1.01%)

SWK

Stanley Black & Decker

$144.36 /

+1.91 (+1.34%)

VRNT

Verint

$63.10 /

+0.55 (+0.88%)

ZBRA

Zebra Technologies

$226.58 /

+0.97 (+0.43%)

  • 16

    Apr

  • 17

    Apr

  • 18

    Apr

  • 19

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 30

    Apr

  • 02

    May

  • 07

    May

  • 07

    May

  • 23

    May

  • 30

    May

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Nov

AAXN Axon
$60.89 /

+0.77 (+1.28%)

04/08/19
Axon upgraded to Strong Buy at Raymond James
04/08/19 Raymond James
Axon upgraded to Strong Buy from Outperform at Raymond James
04/05/19 Dougherty
Axon upgraded to Buy from Neutral at Dougherty
03/19/19 Northcoast
Axon upgraded to Buy from Neutral at Northcoast
ABB ABB
$19.51 /

+0.07 (+0.36%)

03/04/19 DNB Markets
ABB downgraded to Hold from Buy at DNB Markets
01/28/19 Berenberg
ABB downgraded to Sell from Hold at Berenberg
01/15/19 RBC Capital
ABB initiated with a Sector Perform at RBC Capital
01/10/19 Vertical Research
ABB downgraded to Sell from Hold at Vertical Research
ABM ABM
$37.00 /

-0.01 (-0.03%)

04/05/19 KeyBanc
ABM initiated with a Sector Weight at KeyBanc
02/14/19
Fly Intel: Top five analyst initiations
02/14/19 Maxim
ABM initiated with a Buy at Maxim
01/11/19 CL King
ABM downgraded to Neutral from Buy at CL King
AES AES Corp.
$18.07 /

+0.02 (+0.11%)

07/02/18 BofA
AES Corp. downgraded to Underperform from Neutral at BofA/Merrill
05/16/18
AES Corp. downgraded to Neutral on valuation at BofA/Merrill
05/16/18 BofA
AES Corp. downgraded to Neutral from Buy at BofA/Merrill
05/09/18 Scotiabank
AES Corp. upgraded to Sector Perform from Underperform at Scotiabank
AXE Anixter
$59.99 /

-0.37 (-0.61%)

07/20/18
On The Fly: Top five analyst upgrades
07/20/18
Anixter upgraded to Buy on evidence of acceleration in N.A. spending at Longbow
07/20/18 Longbow
Anixter upgraded to Buy from Neutral at Longbow
BCO Brink's
$79.76 /

+0.92 (+1.17%)

10/15/18 SunTrust
Brink's price target lowered to $90 from $98 at SunTrust
09/12/18 Berenberg
Brink's initiated with a Buy at Berenberg
09/12/18 Imperial Capital
Brink's shares 'highly attractive' despite estimate cuts, says Imperial Capital
05/31/18 Buckingham
Brink's price target raised to $110 from $100 at Buckingham
COF Capital One
$86.27 /

+0.67 (+0.78%)

02/26/19
Fly Intel: Top five analyst upgrades
02/26/19 Sandler O'Neill
Sandler O'Neill upgrades Ally Financial to Buy, says valuation premium warranted
02/11/19 KeyBanc
Workday price target raised to $216 from $179 at KeyBanc
02/05/19 Nomura Instinet
Nomura tells investors to 'rethink their cautiousness' on Synchrony
DELL Dell Technologies
$63.84 /

+0.57 (+0.90%)

04/11/19
Fly Intel: Top five analyst initiations
04/11/19 Credit Suisse
Dell Technologies initiated with a Neutral at Credit Suisse
03/04/19 BMO Capital
Dell Technologies price target raised to $52 from $48 at BMO Capital
03/04/19 Maxim
VMware's AWS synergies likely priced in, says Maxim
DMRC Digimarc
$31.19 /

+0.61 (+1.99%)

03/05/19 Lake Street
Digimarc initiated with a Buy at Lake Street
FLIR Flir Systems
$49.32 /

+0.53 (+1.09%)

03/18/19
Flir Systems downgraded to Outperform from Strong Buy at Raymond James
03/18/19 Raymond James
Flir Systems downgraded to Outperform from Strong Buy at Raymond James
02/20/19 Imperial Capital
Flir Systems price target raised to $56 from $51 at Imperial Capital
02/14/19 SunTrust
Flir Systems price target raised to $60 from $55 at SunTrust
INVE Identiv
$4.68 /

-0.06 (-1.27%)

01/14/19 Lake Street
Identiv selloff not reflective of growth opportunities, says Lake Street
09/04/18 Lake Street
Identiv initiated with a Buy at Lake Street
08/01/18 Roth Capital
Identiv initiated with a Buy at Roth Capital
07/09/18 Maxim
Identiv initiated with a Buy at Maxim
NICE Nice
$125.50 /

+0.66 (+0.53%)

03/29/19 Jefferies
Nice Systems can hit $2B in sales before five year goal, says Jefferies
03/28/19 JPMorgan
Verint price target raised to $63 from $59 at JPMorgan
02/15/19 Wedbush
Nice Systems price target raised to $145 from $130 at Wedbush
02/15/19 Jefferies
Nice Systems remains a top mid-cap pick at Jefferies
REZI Resideo
$19.96 /

+0.07 (+0.35%)

03/12/19
Fly Intel: Top five analyst initiations
03/12/19 Imperial Capital
Resideo initiated with an Outperform at Imperial Capital
12/06/18 BofA
Resideo initiated with a Buy at BofA/Merrill
10/30/18 Credit Suisse
Honeywell price target lowered to $158 from $165 at Credit Suisse
SSTI ShotSpotter
$45.84 /

-0.47 (-1.01%)

03/05/19
ShotSpotter files to sell an aggregate of 386k shares of common stock
02/21/19 Imperial Capital
ShotSpotter downgraded to In-Line from Outperform at Imperial Capital
02/20/19 Baird
ShotSpotter price target raised to $58 from $41 at Baird
02/20/19 B. Riley FBR
ShotSpotter price target raised to $59 from $53 at B. Riley FBR
SWK Stanley Black & Decker
$144.36 /

+1.91 (+1.34%)

03/22/19 Longbow
Stanley Black & Decker upgraded to Buy on Craftsman deal benefits at Longbow
03/22/19 Longbow
Stanley Black & Decker upgraded to Buy from Neutral at Longbow
03/06/19 Wells Fargo
Stanley Black & Decker price target raised to $150 from $141 at Wells Fargo
01/23/19 Wells Fargo
Stanley Black & Decker price target lowered to $141 from $150 at Wells Fargo
VRNT Verint
$63.10 /

+0.55 (+0.88%)

04/11/19 Jefferies
Verint price target raised to $72 from $66 at Jefferies
03/29/19 Imperial Capital
Verint price target raised to $65 from $58 at Imperial Capital
03/28/19 Oppenheimer
Verint price target raised to $65 from $60 at Oppenheimer
03/28/19 Wedbush
Verint price target raised to $63 from $58 at Wedbush
ZBRA Zebra Technologies
$226.58 /

+0.97 (+0.43%)

03/15/19 JPMorgan
Zebra Technologies price target raised to $225 from $212 at JPMorgan
03/07/19 Needham
Zebra Technologies price target raised to $225 from $215 at Needham
03/07/19 Berenberg
Zebra Technologies initiated with a Buy at Berenberg
02/21/19 Imperial Capital
Zebra Technologies price target raised to $225 from $195 at Imperial Capital

TODAY'S FREE FLY STORIES

Periodicals
Intuit near deal to buy Credit Karma for $7B in cash and stock, WSJ reports » 09:58
02/23/20
02/23
09:58
02/23/20
09:58
INTU

Intuit

$297.77 /

-3.47 (-1.15%)

Intuit is nearing a deal…

Intuit is nearing a deal to buy Credit Karma for about $7B in cash and stock, Wall Street Journal's Cara Lombardo and Dana Cimilluca report, citing people familiar with the matter. The maker of TurboTax could announce a deal to buy privately held Credit Karma by Monday, assuming talks don't fall apart, the people said. Credit Karma was valued at roughly $4B in a private share sale about two years ago, the authors note. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Volkswagen to face first U.S. jury trial, Bloomberg reports » 07:29
02/23/20
02/23
07:29
02/23/20
07:29
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen faces a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Twitter suspends group of pro-Bloomberg accounts over manipulation, Reuters says » 07:26
02/23/20
02/23
07:26
02/23/20
07:26
TWTR

Twitter

$38.31 /

-0.73 (-1.87%)

Twitter said it had…

Twitter said it had started suspending and restricting dozens of accounts posting content promoting U.S. Democratic presidential candidate Michael Bloomberg, Reuters' Elizabeth Culliford writes. "We took enforcement action on about 70 accounts, which includes a combination of permanent suspensions and account challenges to verify ownership," a Twitter spokeswoman said in a statement to Reuters. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Boeing finds debris inside 737 Max fuel tanks, Reuters reports » 07:24
02/23/20
02/23
07:24
02/23/20
07:24
BA

Boeing

$330.39 /

-5.885 (-1.75%)

Boeing has confirmed it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/23/20
02/23
04:55
02/23/20
04:55
ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

, AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

, ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

, ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

, AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

, BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

, CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

, CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.48 /

+0.38 (+7.45%)

, GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

, GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, INCY

Incyte

$80.89 /

-1.88 (-2.27%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

, MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

, MRK

Merck

$82.34 /

-0.14 (-0.17%)

, NVS

Novartis

$96.75 /

+0.44 (+0.46%)

, PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

, RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

, SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

, SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

, TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

American Society for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett 'almost certain' stocks will beat bonds if current rates, taxes hold » 14:21
02/22/20
02/22
14:21
02/22/20
14:21
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, SPY

SPDR S&P 500 ETF Trust

$333.48 /

-3.49 (-1.04%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "What we can say is that if something close to current rates should prevail over the coming decades and if corporate tax rates also remain near the low level businesses now enjoy, it is almost certain that equities will over time perform far better than long-term, fixed-rate debt instruments."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett's Berkshire spent $5B buying back own shares in 2019 » 14:19
02/22/20
02/22
14:19
02/22/20
14:19
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "In past reports, we've discussed both the sense and nonsense of stock repurchases. Our thinking, boiled down: Berkshire will buy back its stock only if a) Charlie and I believe that it is selling for less than it is worth and b) the company, upon completing the repurchase, is left with ample cash. Calculations of intrinsic value are far from precise. Consequently, neither of us feels any urgency to buy an estimated $1 of value for a very real 95 cents. In 2019, the Berkshire price/value equation was modestly favorable at times, and we spent $5 billion in repurchasing about 1% of the company. Over time, we want Berkshire's share count to go down. If the price-to-value discount (as we estimate it) widens, we will likely become more aggressive in purchasing shares. We will not, however, prop the stock at any level."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett says Berkshire '100% prepared' for his, Munger's departure » 14:17
02/22/20
02/22
14:17
02/22/20
14:17
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "Charlie and I long ago entered the urgent zone. That's not exactly great news for us. But Berkshire shareholders need not worry: Your company is 100% prepared for our departure. The two of us base our optimism upon five factors. First, Berkshire's assets are deployed in an extraordinary variety of wholly or partly-owned businesses that, averaged out, earn attractive returns on the capital they use. Second, Berkshire's positioning of its "controlled" businesses within a single entity endows it with some important and enduring economic advantages. Third, Berkshire's financial affairs will unfailingly be managed in a manner allowing the company to withstand external shocks of an extreme nature. Fourth, we possess skilled and devoted top managers for whom running Berkshire is far more than simply having a high-paying and/or prestigious job. Finally, Berkshire's directors - your guardians - are constantly focused on both the welfare of owners and the nurturing of a culture that is rare among giant corporations...Today, my will specifically directs its executors - as well as the trustees who will succeed them in administering my estate after the will is closed - not to sell any Berkshire shares. My will also absolves both the executors and the trustees from liability for maintaining what obviously will be an extreme concentration of assets."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Berkshire Hathaway reports Q4 net earnings $4.42B vs. $5.72B last year » 14:06
02/22/20
02/22
14:06
02/22/20
14:06
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

At December 31, 2019,…

At December 31, 2019, Berkshire's insurance float was approximately $129B, an increase of $6B since year-end 2018.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
CommScope downgraded to Hold from Buy at Deutsche Bank » 14:02
02/22/20
02/22
14:02
02/22/20
14:02
COMM

CommScope

$12.62 /

+0.07 (+0.56%)

Deutsche Bank analyst…

Deutsche Bank analyst Vijay Bhagavath downgraded CommScope to Hold from Buy citing expected 2020 volatility following the company's Q4 results.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Warren Buffet right to scarf up Kroger stock, Barron's says » 10:24
02/22/20
02/22
10:24
02/22/20
10:24
KR

Kroger

$30.31 /

+0.53 (+1.78%)

, WMT

Walmart

$118.58 /

+0.86 (+0.73%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

Warren Buffett's…

Warren Buffett's Berkshire Hathaway (BRK.B) recently paid $549M for a 2.3% stake in Kroger (KR) as the chain grows digital sales by 21% year over year, Jack Hough writes in this week's edition of Barron's. Kroger goes for less than 13 times projected earnings, a 45% discount to Walmart (WMT), the author notes, adding, however, that both companies are expected to increase earnings per share by 4% to 6% during the year through January 2021. And Kroger stands to benefit indirectly as traditional supermarket shoppers migrate to Walmart.com, he contends. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Virgin Galactic stock outperformance 'just hype,' Barron's says » 10:19
02/22/20
02/22
10:19
02/22/20
10:19
SPCE

Virgin Galactic

$33.70 /

-3.49 (-9.38%)

The latest frenzy…

The latest frenzy infecting stocks may be Virgin Galactic, which could very well be the "frothiest stock around right now," Tae Kim writes in this week's edition of Barron's. But even if Virgin Galactic does actually launch a commercial space-tourism business, its market dominance is not assured, the author notes. Noting that Investors need to assess Virgin Galactic's risks, given rising competitive threats, high expectations for space tourism, and a spotty record for meeting deadlines, Kim says the current stock price may look "pretty irrational." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Caterpillar stock looks cheap, Barron's says » 07:32
02/22/20
02/22
07:32
02/22/20
07:32
CAT

Caterpillar

$137.25 /

+0.325 (+0.24%)

Caterpillar stock has…

Caterpillar stock has dipped to $137 from $150 at the start of this year, while the broad U.S. market has nudged a few percent higher, Jack Hough writes in this week's edition of Barron's. While the author acknowledges that fewer than half of analysts who cover the stock recommend buying it, Hough tells investors to consider doing so just the same. This year's earnings could mark a near-term trough for Caterpillar, while the stock's current valuation implies that U.S. economy is about to slip into recession, which seems unlikely, he argues. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Intelsat could be 'a casualty' in brewing 5G showdown, Barron's says » 07:29
02/22/20
02/22
07:29
02/22/20
07:29
I

Intelsat

$4.50 /

-0.03 (-0.66%)

Intelsat's stock…

Intelsat's stock could again become a casualty in a 5G showdown among hedge-fund managers, satellite operators, and the federal government, Alexandra Scaggs writes in this week's edition of Barron's. The company's satellites transmit television signals over the so-called C-band, which is considered to be prime for fifth-generation, or 5G, service, with regulators wanting to clear out 60% of it for use by wireless companies, the authors note. A consortium of satellite operators called the C-Band Alliance volunteered to sell the spectrum privately in a plan that could have brought Intelsat as much as $24B, but the problem is that a private sale would require the Federal Communications Commission to give satellite operators the ability to sell rights they do not currently have, in the regulator's view, the author adds. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Week in Review: How Trump's policies moved stocks » 07:19
02/22/20
02/22
07:19
02/22/20
07:19
GE

General Electric

$12.24 /

-0.285 (-2.28%)

, HON

Honeywell

$179.90 /

-0.78 (-0.43%)

, AMAT

Applied Materials

$64.27 /

-2.15 (-3.24%)

, LRCX

Lam Research

$316.74 /

-11.65 (-3.55%)

, MU

Micron

$56.98 /

-2.03 (-3.44%)

, WDC

Western Digital

$67.00 /

-2.04 (-2.95%)

, LITE

Lumentum

$83.21 /

-3.13 (-3.63%)

, ACIA

Acacia Communications

$68.69 /

-0.07 (-0.10%)

, NPTN

NeoPhotonics

$7.20 /

-0.31 (-4.13%)

, IIVI

II-VI

$34.73 /

-2.39 (-6.44%)

, ANTM

Anthem

$294.81 /

+0.48 (+0.16%)

, CNC

Centene

$65.41 /

-0.33 (-0.50%)

, CVS

CVS Health

$71.53 /

-0.42 (-0.58%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, MOH

Molina Healthcare

$149.82 /

-0.72 (-0.48%)

, UNH

UnitedHealth

$301.26 /

-0.705 (-0.23%)

, CUDA

Barracuda

$0.00 /

+ (+0.00%)

, CHKP

Check Point

$116.32 /

-1.21 (-1.03%)

, FFIV

F5 Networks

$133.38 /

+0.49 (+0.37%)

, FEYE

FireEye

$15.49 /

-0.19 (-1.21%)

, FTNT

Fortinet

$114.41 /

-3.62 (-3.07%)

, IMPV

Imperva

$0.00 /

+ (+0.00%)

, PANW

Palo Alto Networks

$242.86 /

-6.24 (-2.51%)

, PFPT

Proofpoint

$123.84 /

-1.97 (-1.57%)

, QLYS

Qualys

$91.49 /

-2.8 (-2.97%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/22/20
02/22
04:55
02/22/20
04:55
ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

, AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

, ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

, ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

, AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

, BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

, CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

, CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.48 /

+0.38 (+7.45%)

, GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

, GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, INCY

Incyte

$80.89 /

-1.88 (-2.27%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

, MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

, MRK

Merck

$82.34 /

-0.14 (-0.17%)

, NVS

Novartis

$96.75 /

+0.44 (+0.46%)

, PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

, RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

, SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

, SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

, TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

American Society for…

American Society for Transplantation & Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) hold the 2020 TCT: Transplantation & Cellular Therapy Meeting will be held in Orlando on February 19-23.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eBay says Payments expected to generate $2B of revenue by 2022 » 18:42
02/21/20
02/21
18:42
02/21/20
18:42
EBAY

eBay

$38.19 /

+0.51 (+1.35%)

In addition to…

In addition to eBay's portfolio review, the company's management team has executed numerous value creating actions since the beginning of 2019 that are transforming eBay's business and strengthening its foundation for growth. Among others, these actions include: Scaled Managed Payments in the U.S. and Germany; by 2022, Payments is expected to generate $2B of revenue and $0.5B of operating income; Delivered a point of margin improvement and committed to at least 2 additional points of margin expansion by 2022 while investing in revenue growth initiatives; Executed $5B in share buybacks and recently announced expansion of 2020 share buyback plan from $1.5B to $4.5B; Implemented eBay's first ever dividend and committed to a 14% increase in 2020; Increased focus on Marketplace volume growth with a reorganization of the executive leadership team and a re-prioritized customer-focused plan that includes improved vertical buyer experiences, more data & tools for sellers, and increased platform conversion leveraging an expanded structured data foundation. eBay's Board and management team are confident that the above actions will help achieve the previously stated priorities for 2020 and position eBay for sustainable, profitable long-term growth.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eBay says in 'active discussions with multiple parties' for sale of Classifieds » 18:39
02/21/20
02/21
18:39
02/21/20
18:39
EBAY

eBay

$38.19 /

+0.51 (+1.35%)

eBay issued the following…

eBay issued the following statement regarding the previously announced strategic review of eBay's Classifieds Group: "eBay has been exploring potential value-creating alternatives for Classifieds and continues to be in active discussions with multiple parties regarding a potential transaction. As previously noted, eBay expects to provide an update regarding this process by the middle of the year. eBay remains committed to maximizing the value of Classifieds for eBay shareholders. eBay's Board and management are committed to driving significant returns to shareholders by maximizing the value of Classifieds and positioning our Marketplace business for long-term success," said Scott Schenkel, interim CEO of eBay. "The Classifieds review process, together with the StubHub sale and our initiatives to increase volume, revenues, margins, and cash flow while continuing to invest in long-term profitable growth, demonstrate this commitment. We are acting with urgency while focusing on the ultimate objective of maximizing the value of Classifieds."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Italy reports first coronavirus-related death, Bloomberg says » 17:47
02/21/20
02/21
17:47
02/21/20
17:47
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$333.48 /

-3.49 (-1.04%)

Bloombereg cites…

Bloombereg cites Corriere.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Citi sees 'reasonably possible' legal costs of up to $1.3B in aggregate » 17:46
02/21/20
02/21
17:46
02/21/20
17:46
C

Citi

$76.45 /

-1.76 (-2.25%)

According to a regulatory…

According to a regulatory filing, Citi estimated that the reasonably possible unaccrued loss for various legal matters ranges up to roughly $1.3B in the aggregate. For some of the matters included within this estimation, an accrual has been made because a loss is believed to be both probable and reasonably estimable, but an exposure to loss exists in excess of the amount accrued. In these cases, the estimate reflects the reasonably possible range of loss in excess of the accrued amount. For other matters included within this estimation, no accrual has been made because a loss, although estimable, is believed to be reasonably possible, but not probable; in these cases, the estimate reflects the reasonably possible loss or range of loss. As of December 31, 2019, Citigroup estimates that the reasonably possible unaccrued loss for these matters ranges up to approximately $1.3B in the aggregate. These estimates are based on currently available information. As available information changes, the matters for which Citigroup is able to estimate will change, and the estimates themselves will change. In addition, while many estimates presented in financial statements and other financial disclosures involve significant judgment and may be subject to significant uncertainty, estimates of the range of reasonably possible loss arising from litigation and regulatory proceedings are subject to particular uncertainties.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
WarnerMedia's HBO Max to include reunion special of 'Friends,' WSJ reports » 17:41
02/21/20
02/21
17:41
02/21/20
17:41
T

AT&T

$38.54 /

-0.075 (-0.19%)

WarnerMedia's HBO…

WarnerMedia's HBO Max service will include a special reunion of the television series "Friends" as well as all of the show's previous episodes when the streaming service rolls out in May, the Wall Street Journal's Allison Prang and Joe Flint report. The company said that all six of the main stars of "Friends" will be part of the reunion special, the authors say. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FleetCor's Johnson sells 15,000 common shares » 17:35
02/21/20
02/21
17:35
02/21/20
17:35
FLT

FleetCor

$308.94 /

-8.45 (-2.66%)

In a regulatory filing,…

In a regulatory filing, FleetCor Technologies director Mark A. Johnson disclosed the sale of 15,000 common shares of the company at a price of $321.333 per share on February 19.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon wants internal DOD documents in JEDI cloud case, Bloomberg reports » 17:31
02/21/20
02/21
17:31
02/21/20
17:31
AMZN

Amazon.com

$2,094.29 /

-58.64 (-2.72%)

, MSFT

Microsoft

$178.46 /

-5.9 (-3.20%)

Amazon (AMZN) has asked a…

Amazon (AMZN) has asked a court to force the U.S. government to provide documents related to Defense Secretary Mark Esper's decision to recuse himself from making decisions on the $10B JEDI cloud contract that the Pentagon awarded to Microsoft (MSFT) in December, Bloomberg's Naomi Nix reports. According to a court filing, Amazon is eyeing a trove of documents to strengthen its challenge of the Pentagon's JEDI cloud contract, Nix says. Amazon has claimed that U.S. President Donald Trump's meddling in the matter cost the ecommerce giant the contract, Nix notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Idexx Laboratories director sells 39.1K shares of common stock » 17:29
02/21/20
02/21
17:29
02/21/20
17:29
IDXX

Idexx Laboratories

$278.55 /

-2.92 (-1.04%)

In a regulatory filing,…

In a regulatory filing, Idexx Laboratories disclosed that its director Jonathan Ayers sold 39.1K shares of common stock on February 19th. The total transaction size was about $11.5M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Jernigan Capital cuts quarterly dividend to 23c from 35c per share » 17:24
02/21/20
02/21
17:24
02/21/20
17:24
JCAP

Jernigan Capital

$20.30 /

+0.07 (+0.35%)

The dividend is payable…

The dividend is payable on April 15, 2020 to stockholders of record on April 1, 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.